Results 121 to 130 of about 24,049 (149)

Supplementary Figure S1 from Durvalumab versus Physician’s Choice Chemotherapy in Recurrent Ovarian Clear Cell Adenocarcinoma (MOCCA/APGOT-OV2/GCGS-OV3): A Multicenter, Randomized, Phase 2 Trial

Natalie Y.L. Ngoi, Chel Hun Choi, Junxian Zhu, Diana Lim, Tuan Zea Tan, Haoyang Sun, Valerie Heong, Samuel G.W. Ow, Wen Yee Chay, Hee Seung Kim, Yi Wan Lim, Siew Eng Lim, Geraldine Goss, Jeffrey C. Goh, Jae‐Weon Kim, Michael Friedlander, Bee Choo Tai, Kidong Kim, David S.P. Tan   +18 more
openalex   +1 more source

Addendum 1: Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma. [PDF]

J Immunother Cancer
europepmc   +1 more source

A case report of malignant hypertension and multiorgan dysfunction during immunotherapy for gallbladder cancer. [PDF]

Front Oncol
Anthon C, Pierret H, Houssiau F, De Cuyper A, Van Marcke C, Van Den Eynde M, Mazzeo F, Cornelis F, Galot R, Duhoux FP, Baurain JF, Seront E.   +11 more
europepmc   +1 more source

Pancreatitis associated with immune checkpoint inhibitors: a pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) database. [PDF]

Front Pharmacol
Huang L, Wang H, Wu N.
europepmc   +1 more source

Immune-Checkpoint Inhibitors for Biliary Tract Cancer: Who Benefits and What Is Next? [PDF]

Cancers (Basel)
Ceniceros L, Torre M, Landa Magdalena A, Sangro P, Argemí J, D'Avola D, Sangro B, Ponz-Sarvisé M.   +7 more
europepmc   +1 more source

Supplementary Figure S9 from Durvalumab ± Tremelimumab + Platinum-Etoposide in Extensive-Stage Small Cell Lung Cancer (CASPIAN): Outcomes by PD-L1 Expression and Tissue Tumor Mutational Burden

Luis Paz‐Ares, Marina Chiara Garassino, Yuanbin Chen, Niels Reinmuth, Katsuyuki Hotta, Artem Poltoratskiy, Dmytro Trukhin, Maximilian J. Hochmair, Mustafa Özgüroğlu, Jun Ho Ji, Galina Statsenko, Nikolay Conev, Igor Bondarenko, Libor Havel, György Losonczy, Mingchao Xie, Zhongwu Lai, Nadia Godin-Heymann, Helen Mann, Haiyi Jiang, Yashaswi Shrestha, Jonathan W. Goldman   +21 more
openalex   +1 more source